In addition, mutations that affect intron consensus sequences at the splice and branch sites of BRCA1 and BRCA2 and those that create ectopic splice sites account for 15% of point mutations associated with breast and ovarian cancer (Krawczak et al. The gene discussed is BRCA2; the disease is ovarian cancer.